For the 3rd consecutive year, GT’s Tel Aviv office and members of the firm’s Israel Practice have been recognized by IsraelDesks‘ Legally Israel 100 directory.
Our Israel team has been recognized in the below categories:

…

In July 2019 the IRS identified post offshore voluntary disclosure program (OVDP) compliance as a campaign. The purpose of the campaign is to pursue those OVDP participants who fail to remain compliant with their foreign income and asset reporting requirements. The campaign said that the IRS would address this tax noncompliance through soft letters and

…

Global law firm Greenberg Traurig, LLP’s Trade Secrets Practice was recognized in The Legal 500 U.S. 2020 Guide under the category, “Intellectual property – Trade secrets (litigation and non-contentious matters).” The recognitions are based on feedback from 300,000 clients worldwide, law firm submissions, and interviews with private practice lawyers, in addition to Legal 500’s…

We are pleased to announce that in the recently released ranking by Israeli league table Legally Israel 100, Greenberg Traurig’s Tel Aviv office has been recognized in nine categories, more than any other firm recognized in this year’s rankings. These areas include M&A Volume, M&A Value, Real Estate, Litigation, Employment, IP, Capital Markets, Venture …

Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration under 28 U.S.C. § 1782. Section 1782 is a powerful tool that permits litigants to obtain broad discovery in the United States for use in…

Congratulations to Greenberg Traurig’s Lori Cohen, Marc Mukasey, and Todd Wozniak, who have been selected as  2018 MVPs. The MVP series showcases standout attorneys who have had significant client wins and contributions to their practice areas in the last year.

Lori, Marc, and Todd have a strong commitment to an elite level of client service,…

GT is pleased to have achieved a win on behalf of our client Teva Pharmaceuticals USA, Inc.

In May 2018, a U.S. Federal District Court Judge from the Central District of California granted Teva’s motion to dismiss in its entirety without leave to amend.

In April 2017, Plaintiffs commenced an action in California’s Riverside County …